Furukawa TA - Search Results

1

Family interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis.

Rodolico A, Bighelli I, Avanzato C, Concerto C, Cutrufelli P, Mineo L, Schneider-Thoma J, Siafis S, Signorelli MS, Wu H, Wang D, Furukawa TA, Pitschel-Walz G, Aguglia E, Leucht S. Rodolico A, et al. Among authors: furukawa ta. Lancet Psychiatry. 2022 Mar;9(3):211-221. doi: 10.1016/S2215-0366(21)00437-5. Epub 2022 Jan 31. Lancet Psychiatry. 2022. PMID: 35093198

2

Relative indices of treatment effect may be constant across different definitions of response in schizophrenia trials.

Furukawa TA, Akechi T, Wagenpfeil S, Leucht S. Furukawa TA, et al. Schizophr Res. 2011 Mar;126(1-3):212-9. doi: 10.1016/j.schres.2010.10.016. Epub 2010 Nov 9. Schizophr Res. 2011. PMID: 21062670 Free article.

3

How to obtain NNT from Cohen's d: comparison of two methods.

Furukawa TA, Leucht S. Furukawa TA, et al. PLoS One. 2011 Apr 27;6(4):e19070. doi: 10.1371/journal.pone.0019070. PLoS One. 2011. PMID: 21556361 Free PMC article.

4

Can we inflate effect size and thus increase chances of producing "positive" results if we raise the baseline threshold in schizophrenia trials?

Furukawa TA, Leucht S. Furukawa TA, et al. Schizophr Res. 2013 Mar;144(1-3):105-8. doi: 10.1016/j.schres.2012.12.006. Epub 2013 Jan 9. Schizophr Res. 2013. PMID: 23312551 Free article.

5

Imputation of response rates from means and standard deviations in schizophrenia.

Samara MT, Spineli LM, Furukawa TA, Engel RR, Davis JM, Salanti G, Leucht S. Samara MT, et al. Among authors: furukawa ta. Schizophr Res. 2013 Dec;151(1-3):209-14. doi: 10.1016/j.schres.2013.10.029. Epub 2013 Nov 18. Schizophr Res. 2013. PMID: 24262679

6

Azapirones versus placebo for panic disorder in adults.

Imai H, Tajika A, Chen P, Pompoli A, Guaiana G, Castellazzi M, Bighelli I, Girlanda F, Barbui C, Koesters M, Cipriani A, Furukawa TA. Imai H, et al. Among authors: furukawa ta. Cochrane Database Syst Rev. 2014 Sep 30;2014(9):CD010828. doi: 10.1002/14651858.CD010828.pub2. Cochrane Database Syst Rev. 2014. PMID: 25268297 Free PMC article. Review.

7

Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.

Furukawa TA, Levine SZ, Tanaka S, Goldberg Y, Samara M, Davis JM, Cipriani A, Leucht S. Furukawa TA, et al. JAMA Psychiatry. 2015 Jan;72(1):14-21. doi: 10.1001/jamapsychiatry.2014.2127. JAMA Psychiatry. 2015. PMID: 25372935

8

Dose Equivalents for Second-Generation Antipsychotic Drugs: The Classical Mean Dose Method.

Leucht S, Samara M, Heres S, Patel MX, Furukawa T, Cipriani A, Geddes J, Davis JM. Leucht S, et al. Schizophr Bull. 2015 Nov;41(6):1397-402. doi: 10.1093/schbul/sbv037. Epub 2015 Apr 3. Schizophr Bull. 2015. PMID: 25841041 Free PMC article. Review.

9

Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.

Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, Barbui C, Leucht S, Furukawa TA. Hayasaka Y, et al. Among authors: furukawa ta. J Affect Disord. 2015 Jul 15;180:179-84. doi: 10.1016/j.jad.2015.03.021. Epub 2015 Mar 31. J Affect Disord. 2015. PMID: 25911132 Free article.

10

Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis.

Miura T, Noma H, Furukawa TA, Mitsuyasu H, Tanaka S, Stockton S, Salanti G, Motomura K, Shimano-Katsuki S, Leucht S, Cipriani A, Geddes JR, Kanba S. Miura T, et al. Among authors: furukawa ta. Lancet Psychiatry. 2014 Oct;1(5):351-9. doi: 10.1016/S2215-0366(14)70314-1. Epub 2014 Oct 7. Lancet Psychiatry. 2014. PMID: 26360999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

695 results

Search Page